NO961616D0 - Kromon-derivater - Google Patents
Kromon-derivaterInfo
- Publication number
- NO961616D0 NO961616D0 NO961616A NO961616A NO961616D0 NO 961616 D0 NO961616 D0 NO 961616D0 NO 961616 A NO961616 A NO 961616A NO 961616 A NO961616 A NO 961616A NO 961616 D0 NO961616 D0 NO 961616D0
- Authority
- NO
- Norway
- Prior art keywords
- chromone derivatives
- chromone
- derivatives
- Prior art date
Links
- 150000004777 chromones Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/08—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH115795 | 1995-04-24 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO961616D0 true NO961616D0 (no) | 1996-04-23 |
| NO961616L NO961616L (no) | 1996-10-25 |
| NO309813B1 NO309813B1 (no) | 2001-04-02 |
Family
ID=4203819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO961616A NO309813B1 (no) | 1995-04-24 | 1996-04-23 | Nye 1-acylpiperidinforbindelser, farmasøytiske preparater inneholdende disse, samt anvendelse derav til behandling av sykdommer som viser respons pÕ antagonisering av NK1-reseptoren |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5604247A (no) |
| EP (1) | EP0739892B1 (no) |
| JP (1) | JP3068458B2 (no) |
| KR (1) | KR100416674B1 (no) |
| CN (1) | CN1063176C (no) |
| AR (1) | AR001813A1 (no) |
| AT (1) | ATE224891T1 (no) |
| AU (1) | AU714523B2 (no) |
| BR (1) | BR9602025A (no) |
| CA (1) | CA2174707C (no) |
| DE (1) | DE59609707D1 (no) |
| DK (1) | DK0739892T3 (no) |
| ES (1) | ES2183923T3 (no) |
| HU (1) | HUP9601062A3 (no) |
| IL (1) | IL117989A (no) |
| NO (1) | NO309813B1 (no) |
| NZ (1) | NZ286422A (no) |
| PT (1) | PT739892E (no) |
| RU (1) | RU2156250C2 (no) |
| TW (1) | TW475930B (no) |
| ZA (1) | ZA963211B (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997044035A1 (en) * | 1996-05-24 | 1997-11-27 | Eli Lilly And Company | Methods of treating hypertension |
| TW426667B (en) * | 1997-11-19 | 2001-03-21 | Pfizer | Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists |
| DK1107744T3 (da) * | 1998-08-25 | 2003-07-28 | Wolfgang Mueller | Anvendelse af substans P antagonister i behandlingen af kronisk træthedssyndrom og/eller fibromyalgi |
| CA2374643C (en) * | 1999-05-21 | 2006-02-14 | Pfizer Products Inc. | 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives as substance p antagonists |
| GB0220953D0 (en) | 2002-09-10 | 2002-10-23 | Novartis Ag | Organic compounds |
| GB2394417A (en) * | 2002-10-24 | 2004-04-28 | Novartis Ag | Solid dispersion comprising a piperidine substance P antagonist and a carrier |
| DE10256174A1 (de) * | 2002-12-02 | 2004-06-09 | Merck Patent Gmbh | 2-Benzoylchromonderivate |
| DE10256182A1 (de) * | 2002-12-02 | 2004-06-24 | Merck Patent Gmbh | 2-Oxadiazolchromonderivate |
| US20050209274A1 (en) * | 2004-02-26 | 2005-09-22 | Lynch John K | Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| CN1300163C (zh) * | 2004-06-23 | 2007-02-14 | 南京大学 | 3－羟基色原酮糖苷及其制法和用途 |
| KR20080111144A (ko) * | 2006-04-18 | 2008-12-22 | 아보트 러보러터리즈 | 바닐로이드 수용체 서브타입 １(ｖｒ１)의 길항제 및 이의 용도 |
| GB0701365D0 (en) * | 2007-01-24 | 2007-03-07 | Glaxo Group Ltd | Novel pharmaceutical compositions |
| UA105182C2 (ru) | 2008-07-03 | 2014-04-25 | Ньюрексон, Інк. | Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3117389A1 (de) * | 1981-05-02 | 1982-11-18 | Boehringer Mannheim Gmbh, 6800 Mannheim | Benzopyranylether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
| MY110227A (en) * | 1991-08-12 | 1998-03-31 | Ciba Geigy Ag | 1-acylpiperindine compounds. |
| AU7856194A (en) * | 1993-10-26 | 1995-05-22 | Ciba-Geigy Ag | N-benzoyl-4-oxy/thio-2-substituted piperidines as substance-p receptor antagonists |
| DE69525355T2 (de) * | 1994-09-30 | 2002-09-19 | Novartis Ag, Basel | 1-acyl-4-aliphatische aminopiperidin verbindungen |
| TW397825B (en) * | 1994-10-14 | 2000-07-11 | Novartis Ag | Aroyl-piperidine derivatives |
-
1996
- 1996-04-11 RU RU96107121/04A patent/RU2156250C2/ru not_active IP Right Cessation
- 1996-04-11 TW TW085104270A patent/TW475930B/zh not_active IP Right Cessation
- 1996-04-16 US US08/632,971 patent/US5604247A/en not_active Expired - Lifetime
- 1996-04-16 AT AT96810237T patent/ATE224891T1/de not_active IP Right Cessation
- 1996-04-16 EP EP96810237A patent/EP0739892B1/de not_active Expired - Lifetime
- 1996-04-16 DE DE59609707T patent/DE59609707D1/de not_active Expired - Lifetime
- 1996-04-16 PT PT96810237T patent/PT739892E/pt unknown
- 1996-04-16 DK DK96810237T patent/DK0739892T3/da active
- 1996-04-16 ES ES96810237T patent/ES2183923T3/es not_active Expired - Lifetime
- 1996-04-21 IL IL11798996A patent/IL117989A/xx active IP Right Grant
- 1996-04-22 NZ NZ286422A patent/NZ286422A/en unknown
- 1996-04-22 AU AU50805/96A patent/AU714523B2/en not_active Ceased
- 1996-04-22 CA CA002174707A patent/CA2174707C/en not_active Expired - Fee Related
- 1996-04-23 JP JP8101568A patent/JP3068458B2/ja not_active Expired - Fee Related
- 1996-04-23 ZA ZA963211A patent/ZA963211B/xx unknown
- 1996-04-23 CN CN96106111A patent/CN1063176C/zh not_active Expired - Fee Related
- 1996-04-23 KR KR1019960012355A patent/KR100416674B1/ko not_active IP Right Cessation
- 1996-04-23 HU HU9601062A patent/HUP9601062A3/hu unknown
- 1996-04-23 NO NO961616A patent/NO309813B1/no unknown
- 1996-04-24 AR AR33626596A patent/AR001813A1/es unknown
- 1996-04-24 BR BR9602025A patent/BR9602025A/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2183923T3 (es) | 2003-04-01 |
| NO309813B1 (no) | 2001-04-02 |
| EP0739892A3 (de) | 1997-01-22 |
| JPH093066A (ja) | 1997-01-07 |
| CN1141921A (zh) | 1997-02-05 |
| ZA963211B (en) | 1996-10-24 |
| CA2174707C (en) | 2008-03-25 |
| AU5080596A (en) | 1996-11-07 |
| HUP9601062A3 (en) | 1998-10-28 |
| KR960037680A (ko) | 1996-11-19 |
| BR9602025A (pt) | 1998-10-06 |
| KR100416674B1 (ko) | 2004-06-11 |
| HUP9601062A2 (en) | 1997-10-28 |
| NO961616L (no) | 1996-10-25 |
| CA2174707A1 (en) | 1996-10-25 |
| EP0739892B1 (de) | 2002-09-25 |
| HU9601062D0 (en) | 1996-06-28 |
| EP0739892A2 (de) | 1996-10-30 |
| DE59609707D1 (de) | 2002-10-31 |
| DK0739892T3 (da) | 2003-01-20 |
| MX9601515A (es) | 1997-09-30 |
| US5604247A (en) | 1997-02-18 |
| RU2156250C2 (ru) | 2000-09-20 |
| AR001813A1 (es) | 1997-12-10 |
| PT739892E (pt) | 2003-01-31 |
| TW475930B (en) | 2002-02-11 |
| JP3068458B2 (ja) | 2000-07-24 |
| AU714523B2 (en) | 2000-01-06 |
| ATE224891T1 (de) | 2002-10-15 |
| IL117989A0 (en) | 1996-08-04 |
| NZ286422A (en) | 1998-01-26 |
| CN1063176C (zh) | 2001-03-14 |
| IL117989A (en) | 2000-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69611361D1 (de) | Chinazolin-derivate | |
| DE69522717D1 (de) | Chinazolinderivate | |
| NO974103D0 (no) | Arylsulfonylaminohydroksamsyre-derivater | |
| DE69610698D1 (de) | Chinazolin-derivate | |
| PT833828E (pt) | Derivados de rapamicina | |
| BR9611834A (pt) | Derivados de oximetóxi-3-aril-pirona | |
| NO964667D0 (no) | Purin-6-on-derivater | |
| ATE199150T1 (de) | Diphenylmethylenpiperidin-derivate | |
| EE200000140A (et) | Asendatud kromaani derivaadid | |
| DE69601527D1 (de) | Pyrrolylbenzimidazol-Derivate | |
| ATA100695A (de) | Prothrombin-derivate | |
| DE59609707D1 (de) | Chromon-Derivate | |
| PT856007E (pt) | Derivados de ciclopeptidos | |
| ATE240307T1 (de) | Diarylalkenylamin-derivate | |
| DE69627830D1 (de) | Pyrazol-derivate | |
| FI973992A (fi) | Bentsopyraaneja | |
| DK0723963T3 (da) | 4-Amino-benzoylguanidin-derivater | |
| DE69601611D1 (de) | Chromanderivate | |
| DE59610106D1 (de) | Fluorbenzylether-Derivate | |
| DK0843675T3 (da) | Aza-anthracyclinonderivater | |
| BR9603508A (pt) | Derivados de alquenil-benzoilguanidina | |
| ATE202088T1 (de) | 4-mercapto-benzoylguanidin-derivate | |
| DE69620514D1 (de) | 5-aminoflavon-derivate | |
| ATA45796A (de) | Lysin-prolin-derivate | |
| BR9603733A (pt) | Derivados de cloropiridilcarbonila |